MedTrace Logo

Cardiovascular Disease Education and Problem-Solving Training in People With Type 2 Diabetes

NCT00964587 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 382

Last updated 2015-05-12

No results posted yet for this study

Summary

The purpose of this study is to determine if patient education and problem-solving training, delivered in self-study, group, and individual intervention modalities, will produce substantial improvements in CVD risk profile via improved self management in urban African Americans with type 2 diabetes and a high CVD risk profile.

Conditions

Interventions

BEHAVIORAL

Education + Problem-Solving Training Self-Study

* Education + Problem-Solving Training Self-Study * One session of Literacy-Adapted Diabetes and CVD Risk Education * Instructions and a schedule for use of the Literacy-Adapted Problem-Solving Workbook for self-study will be given to each participant.

BEHAVIORAL

Education + Group Problem-Solving Training

* Education + Group Problem-Solving Training * One session of the Literacy-Adapted Diabetes and CVD Risk Education * Group problem-solving training eight, 90-minute sessions

BEHAVIORAL

Education + Individual Problem-Solving Training

* Education + Individual Problem-Solving Training * One session of the Literacy-Adapted Diabetes and CVD Risk Education * Individual problem-solving training (eight, 60-minute sessions)

BEHAVIORAL

Usual Care

* Packet of print patient education materials about CVD and diabetes from the American Heart Association (AHA) and the American Diabetes Association (ADA)given at baseline following randomization to Arm 1 * Scripted set of instructions will be given along with a verbal description of the materials and the content provided.

Sponsors & Collaborators

Principal Investigators

  • Felicia Hill-Briggs, PhD, ABPP · Johns Hopkins School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2014-02-28
Completion
2014-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00964587 on ClinicalTrials.gov